The Nasdaq closing bell had barely stopped ringing when the financial world started doing the math. That represented a 68% jump from the $185 offering price and gave the company a market capitalization around $95 billion. CEO Andrew Feldman stood on the podium holding the company’s dinner-plate-sized Wafer Scale Engine 3 chip, and by the end of the session, both he and hardware chief Sean Lie had become billionaires. The cerebras ipo was a landmark moment, but it also set the stage for something far bigger.
The Cerebras IPO: A Validation of Pure-Play AI Hardware
For years, public market investors who wanted exposure to the artificial intelligence boom had limited options. They could buy shares of Nvidia, which designs chips but does not manufacture them. They could invest in cloud providers like Amazon or Microsoft that sell AI services. Or they could take a gamble on smaller firms with indirect exposure. What they could not do was buy a company that builds nothing but massive AI chips from the ground up. Cerebras changed that.
The company’s approach is unusual even by Silicon Valley standards. Instead of cutting silicon wafers into individual chips, Cerebras builds one enormous chip that spans an entire wafer. The Wafer Scale Engine 3 contains 4 trillion transistors and is roughly the size of a dinner plate. This design eliminates the need for interconnects between separate chips, which dramatically speeds up certain types of AI training and inference workloads.
The cerebras ipo raised $5.55 billion, making it the largest US tech IPO since Snowflake’s $3.8 billion debut in 2020. But the numbers only tell part of the story. The real significance lies in what the offering signals about investor appetite for specialized AI hardware. CoreWeave, which went public in March 2025 and now carries a valuation above $58 billion, was the closest prior data point. But CoreWeave sells cloud infrastructure rather than silicon. Cerebras is the first dedicated AI chip company to list since the generative AI boom began, and its opening-day performance suggests that public market demand for AI exposure is at least as aggressive as the private market has been pricing it.
How Cerebras Built Momentum Before the IPO
The company’s revenue trajectory tells a compelling story. In 2022, Cerebras generated just $24.6 million in revenue. By 2025, that figure had grown to $510 million, and the company posted a net income of $88 million. That kind of growth rate is rare even in the fast-moving semiconductor industry.
A major turning point came in January 2026, when Cerebras signed a $20 billion multi-year contract with OpenAI for inference computing capacity. That deal transformed the company’s financial profile and gave it a marquee customer that every institutional investor recognizes. Before that contract, Cerebras was 85% dependent on a single customer, G42, an AI and cloud computing company based in the United Arab Emirates. The OpenAI deal diversified its revenue base and provided the kind of blue-chip anchor that IPO underwriters love to see.
The Co-Founders Who Became Billionaires Overnight
Andrew Feldman and Sean Lie have been working on wafer-scale chips for nearly a decade. Feldman, the company’s CEO, is known for his candid, sometimes irreverent communication style. He has described the Wafer Scale Engine as “the most audacious chip project in the history of semiconductors.” Lie, the hardware chief, is the quieter half of the duo but equally essential to the technical vision.
When Feldman rang the Nasdaq opening bell holding the company’s signature chip, it was a moment of vindication for a bet that many industry observers had dismissed as impractical. Manufacturing a single chip the size of a dinner plate presents enormous engineering challenges. Yield rates, thermal management, and power delivery all become harder at that scale. But Cerebras solved those problems, and the market rewarded that persistence with a $95 billion valuation.
The IPO Drought That Preceded the Cerebras IPO
The cerebras ipo did not happen in a vacuum. It emerged from one of the longest and most severe IPO droughts in recent memory. In 2025, only 31 technology companies went public in the United States. That number stands in stark contrast to the 121 tech IPOs that occurred four years earlier, in 2021. The pipeline had essentially frozen.
Several factors contributed to the freeze. Rising interest rates made growth stocks less attractive to institutional investors. Geopolitical uncertainty, particularly around US-China trade tensions, made companies hesitant to file. And the collapse of several high-profile SPAC mergers had soured the market on alternative paths to public listing. Total US venture-backed exit value did double to $217.1 billion in 2025, but that figure was still less than one-third of the 2021 peak.
Cerebras benefited from this dynamic directly. Investors who had been starved of new AI-related public offerings for years were eager to deploy capital. The company’s wafer-scale technology offered something genuinely different from Nvidia’s GPU architecture, which gave it a differentiation story that resonated with both growth and value investors.
Why the Drought Made Cerebras More Attractive
Scarcity creates demand. With only 31 tech IPOs in 2025, institutional investors had limited opportunities to add new positions in the AI hardware space. Cerebras represented one of the few pure plays available. The company’s $20 billion OpenAI contract provided revenue visibility that many earlier-stage AI companies could not match.
Rick Heitzmann, a partner at venture firm FirstMark, described the cerebras ipo as the signal the market needed. He told CNBC that the strong debut would encourage other companies to pursue public listings. “It’s going to encourage people to say, ‘Hey, jump in, the water’s warm,'” Heitzmann said. But as he and others noted, the warm water was about to receive three entrants whose combined mass could displace everything around them.
The Three Trillion-Dollar IPOs on the Horizon
Sam Lessin, a partner at Slow Ventures, captured the mood of the market in a single sentence. “It’s very hard to care about anything other than the $3 trillion potential IPOs that, in theory, are going to happen in the next year,” he told CNBC. He was referring to SpaceX, OpenAI, and Anthropic, three private companies whose combined valuation approaches $3 trillion.
The cerebras ipo, impressive as it was, now looks like an appetizer. The main course is still being prepared, and it promises to be the largest feast in IPO history.
SpaceX: Targeting the Largest IPO in History
SpaceX merged with Elon Musk’s AI venture xAI in February 2026 at a valuation of $1.25 trillion. According to the Wall Street Journal, the combined entity is now targeting a $1.75 trillion valuation for its public offering. The company aims to raise between $50 billion and $75 billion, which would make it the largest IPO in history, surpassing Saudi Aramco’s $29.4 billion debut in 2019.
The logistics alone are staggering. SpaceX has assembled an underwriting syndicate of at least 21 banks. A global roadshow is expected to begin in early June, with a listing date reportedly targeted for June 12. The company is expected to disclose its IPO prospectus as soon as next week, which would give investors their first detailed look at the financials of the world’s most valuable private company.
SpaceX’s core business has evolved far beyond launching satellites and ferrying astronauts. The company’s Starlink internet constellation now serves millions of subscribers globally, generating recurring revenue that investors love. The xAI merger adds an artificial intelligence dimension that could open up new markets in autonomous space operations and satellite-based computing.
OpenAI: The Most Scrutinized Tech Offering of the Decade
OpenAI is preparing to go public in the fourth quarter of 2026, targeting a valuation of approximately $852 billion. The company closed a $122 billion funding round in March 2026, which gave it the capital base to scale its operations aggressively. CFO Sarah Friar has described the IPO as a “moment to build trust” but has also cautioned that the company is not yet ready to be public.
The offering will face intense scrutiny for several reasons. OpenAI is still embroiled in a legal dispute with Elon Musk, who co-founded the organization before leaving and has since become one of its most vocal critics. The company’s product strategy is also in flux, with ongoing debates about how to balance safety research with commercial deployment. And the company’s chief revenue officer has publicly accused Anthropic of overstating its revenue by $8 billion through gross accounting methods, adding a layer of drama to what is already a high-stakes competition.
Despite these complications, OpenAI’s revenue trajectory is extraordinary. The company’s annualized revenue surged from $9 billion at the end of 2025 to $30 billion by early April 2026, driven largely by enterprise adoption of its advanced models. The $20 billion inference computing contract with Cerebras, signed in January, demonstrates the scale of infrastructure spending required to support that growth.
Anthropic: The Dark Horse with Surging Revenue
Anthropic has attracted investor offers at approximately $800 billion, more than doubling the $380 billion valuation at which it closed a $30 billion funding round just two months earlier. The company is in early talks with Goldman Sachs, JPMorgan, and Morgan Stanley about a listing as early as October 2026.
The company’s revenue growth has been even more dramatic than OpenAI’s. Annualized revenue surged from $9 billion at the end of 2025 to $30 billion by early April 2026. The primary driver has been enterprise adoption of Claude Code, a developer tool that automates large portions of software engineering. Companies are using it to accelerate development cycles, reduce headcount costs, and improve code quality, and they are willing to pay premium prices for the capability.
Anthropic’s valuation trajectory raises an interesting question. If the company can maintain its current growth rate, an $800 billion valuation could eventually look conservative. But the competitive dynamics of the AI industry are brutal. OpenAI, Google, and a host of well-funded startups are all chasing the same enterprise customers. Anthropic’s ability to sustain its momentum will depend on continued technical breakthroughs and effective go-to-market execution.
The Liquidity Question: Can the Market Absorb $150 Billion in Demand?
The combined fundraising demand from SpaceX, OpenAI, and Anthropic is projected to exceed $150 billion. That figure raises genuine questions about market liquidity. Institutional investors will need to allocate capital at a scale that has no precedent in IPO history.
To put that number in perspective, the total amount raised by all US tech IPOs in 2025 was roughly $15 billion. The three upcoming offerings would require ten times that amount in a single year. Even the most optimistic market participants acknowledge that this will strain the system.
Some institutional investors may need to sell existing positions to free up capital for these offerings. That could create downward pressure on the stocks of other technology companies, particularly those in the AI and semiconductor sectors. Others may choose to sit out one or more of the offerings, which could affect pricing and valuation.
The cerebras ipo demonstrated that there is strong demand for AI-related public offerings. But $5.55 billion is a very different number from $150 billion. The market’s ability to absorb all three offerings will depend on continued investor enthusiasm for AI, the overall health of the equity markets, and the specific terms that each company offers.
You may also enjoy reading: Oregon vs Texas Tech: CFP Quarterfinal Preview with Key Stats and History.
How Institutional Investors Are Preparing
Large asset managers are already making contingency plans. Some are setting aside dedicated allocation pools for the three offerings. Others are conducting valuation analyses to determine which of the three companies offers the best risk-reward profile. A few are signaling that they may participate in only one or two of the offerings, forcing the companies to compete for attention.
The underwriting banks face their own challenges. SpaceX has assembled 21 banks for its syndicate, which is an unusually large number. Coordinating that many institutions, each with its own client relationships and allocation preferences, will require careful management. The fees associated with these offerings will be substantial, but so will the reputational risk if any of them goes poorly.
What the Cerebras IPO Means for the Broader Market
The cerebras ipo served as a stress test for the IPO market. It demonstrated that investors are willing to pay premium prices for companies with genuine technological differentiation, strong revenue growth, and credible paths to profitability. It also showed that the public market can absorb large offerings when the story is compelling.
But the offering also exposed a potential problem. The attention and capital that will flow to SpaceX, OpenAI, and Anthropic could crowd out smaller companies that might otherwise have gone public. If the three mega-IPOs consume $150 billion in investor demand, there may be little left for the dozens of smaller AI and technology companies that are also preparing to list.
This dynamic creates a bifurcated market. The largest, most well-known companies will have no trouble raising capital. Smaller firms may struggle to attract attention, even if their technology is innovative and their business models are sound. The cerebras ipo was large enough to command attention but not so large that it overwhelmed the system. The three upcoming offerings are in a different league entirely.
The Ripple Effects on AI Chip Stocks
Cerebras’s strong debut could lift valuations across the AI chip sector. If investors are willing to pay $95 billion for a company with $510 million in revenue, they may reassess the valuations of other semiconductor companies with AI exposure. Nvidia, AMD, and Intel could all benefit from the halo effect, at least in the short term.
But the ripple effects could also create risks. If the three mega-IPOs underperform, the disappointment could spill over into the broader AI sector. Investors who bought Cerebras at $311 may find themselves holding a stock that trades at a significant discount if the market’s attention shifts to SpaceX, OpenAI, and Anthropic.
The Regulatory Landscape for AI IPOs
The Securities and Exchange Commission will play a crucial role in shaping the outcome of these offerings. The SEC has been scrutinizing AI-related disclosures more closely in recent years, particularly around claims about model capabilities and revenue recognition practices.
Anthropic’s revenue recognition practices have already become a point of contention. The company’s CRO publicly accused OpenAI of overstating its revenue by $8 billion through gross accounting methods, a charge that OpenAI has denied. The SEC may look closely at how both companies recognize revenue from enterprise contracts, particularly those that involve complex usage-based pricing models.
SpaceX faces its own regulatory challenges. The company operates in an industry that is heavily regulated by the Federal Aviation Administration and the Federal Communications Commission. Any regulatory setbacks, such as delays in launch licenses or spectrum allocation decisions, could affect investor sentiment.
Disclosure Requirements and Investor Protection
IPO prospectuses for AI companies have become increasingly detailed in recent years. Investors want to understand not just the financials but also the technical architecture, the competitive landscape, and the risk factors associated with rapid technological change.
The cerebras ipo prospectus included extensive discussion of the company’s manufacturing arrangements, its dependence on a single chip foundry for wafer production, and the technical challenges of scaling its architecture to future generations. Those disclosures gave investors a realistic picture of the risks involved, which likely contributed to the offering’s success.
SpaceX, OpenAI, and Anthropic will need to provide similarly detailed disclosures. Given the scale of their offerings, the scrutiny will be intense. Any material omission or misleading statement could trigger shareholder lawsuits and regulatory penalties.
What Comes Next for Cerebras
The cerebras ipo was a spectacular debut, but the company now faces the challenge of living up to its $95 billion valuation. The $20 billion OpenAI contract provides a strong revenue foundation, but the company will need to continue winning new customers and expanding its product lineup to justify the multiple.
Cerebras is already working on next-generation wafer-scale chips that could offer even greater performance. The company is also exploring applications beyond AI training and inference, including scientific computing, drug discovery, and climate modeling. If those markets develop as expected, Cerebras could become a multi-industry platform rather than a single-purpose AI chip company.
The company’s dependence on a single customer has decreased significantly since the OpenAI deal, but it still faces concentration risk. If OpenAI decides to build its own chips or switch to a different supplier, Cerebras would need to replace a substantial portion of its revenue quickly. Diversifying the customer base will be a top priority for management in the coming quarters.
The Bigger Picture: A New Era for Tech IPOs
The cerebras ipo marks the beginning of what could be the most active period for technology public offerings in history. The combination of pent-up demand from the IPO drought, the transformative potential of artificial intelligence, and the sheer scale of the companies preparing to list creates a once-in-a-generation opportunity.
But it also creates risks. The market’s ability to absorb $150 billion in new supply is untested. The valuations of SpaceX, OpenAI, and Anthropic are based on assumptions about future growth that may or may not materialize. And the regulatory environment for AI companies is evolving rapidly, with new rules and guidelines emerging on almost a monthly basis.
Investors who participated in the cerebras ipo got a taste of what is to come. The strong debut validated the thesis that public market investors are hungry for AI exposure. But the real test is still ahead. When SpaceX, OpenAI, and Anthropic hit the public market, the financial world will be watching to see whether the demand matches the hype.
